Navigation Links
Use of high hydrostatic pressure to inactivate Hepatitis A virus in oysters studied

NOAA/Virginia Sea Grant has awarded Virginia Tech $119,000 to study whether high hydrostatic pressure will inactivate Hepatitis A virus in both shucked and unshucked oysters.

The project, led by Daniel Holliman, an M.D. with the High Pressure Processing Laboratory, and Laura Douglas, lab manager, will identify one or more effective high pressure processing schedules. The laboratory is a facility of the Department of Food Science and Technology at Virginia Tech, devoted to improving food safety and food processing.

Hepatitis A virus (HAV) is one of the more serious illnesses transmissible by shellfish. Worldwide, HAV is responsible for more than 1.5 million cases of the disease each year, with 260,000 cases and more than 100 deaths in the United States. Hepatitis A infection is characterized by fatigue, malaise, fever, loss of appetite, nausea, vomiting, joint and muscle aches, and abdominal pain, coupled with the onset of jaundice, a yellowing of the whites of the eyes, and dark urine. The disease generally runs its course in two months, but can linger as long as six. While survival rates for Hepatitis A are above 99 percent, the disease can be very dangerous for infants, the elderly, immunosuppressed people, and those with existing liver disease.

Bivalve shellfish, such as oysters, have been demonstrated to concentrate pathogenic organisms from their environment. In some cases, sewage contamination of harvesting areas, either from coastal runoff or ship discharges, has been shown to result in HAV contamination of oysters. Several studies have demonstrated remarkable concentration and persistence of HAV in shellfish exposed to the virus through their surrounding seawater. Even with depuration, HAV may persist in oysters for several weeks after exposure. The virus also is fairly resistant to heating and may remain viable in shellfish after up to five minutes of steaming.

For these reasons, high hydrostatic pressure treatment of raw oyst ers is especially appealing to oyster processors and distributors, as well as public health officials. HPP makes it possible to eradicate or inactivate pathogens while still delivering a 'raw' product to the consumer.

The study will benefit processors and distributors by mitigating their food safety liability, but most importantly, also will help protect consumers from foodborne infectious disease.

Virginia Sea Grant is part of a 30-state National Sea Grant Program established by Congress in 1966 as part of the National Oceanic and Atmospheric Administration. Sea-grant colleges research new ideas and technologies to help use, manage, and understand ocean and coastal resources. Virginia Sea Grant funds marine science research in aquaculture, seafood safety and quality, marine resources, coastal ecosystems through a competitive, peer-reviewed grant proposal process. In addition to its core programs, Virginia Sea Grant coordinates research in oyster disease and toxics in the Chesapeake Bay.


'"/>

Source:Virginia Tech


Related biology news :

1. Gene therapy to lower blood pressure just enough
2. Researchers learn how blood vessel cells cope with their pressure-packed job
3. Genes affecting blood pressure change as children become adults
4. How nice, brown rice: Study shows rice bran lowers blood pressure in rats
5. Blame the brain for high blood pressure
6. Its OK for men with high blood pressure to have a drink or two, new study finds
7. 8 plants from South Africa may hold potential for treating high blood pressure
8. Scientists Replicate Hepatitis C Virus in Laboratory
9. Norovirus, AIDS vaccine and Hepatitis Virus
10. UCLA study assesses cost-effectiveness of Hepatitis B drugs
11. Natural Killers Could Lead to New Hepatitis Treatments
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... DUBAI , UAE, May 9, 2016 ... choice when it comes to expanding freedom for high ... Even in today,s globally connected world, there ... online conferencing system could ever duplicate sealing your deal ... are obtaining second passports by taking advantage of citizenship ...
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
Breaking Biology Technology: